The investors in ARX Robotics' Series A extension include Speedinvest and HV Capital.
The Disruptive Technologies Innovation Fund (DTIF) awarded LIfT BioSciences a €12 million grant.
The firm's funding round was led by Motion Ventures, with support from EXMAR.